Brief: RLS Global And ConvaTec Sign Agreement
17/06/2021 07:32
June 17 (Reuters) - RLS Global AB RLSC.ST :
* RLS GLOBAL AB AND CONVATEC LTD SIGN AGREEMENT ON GLOBAL
COMMERCIAL RIGHTS FOR CHLORASOLV, AN INNOVATIVE WOUND DEBRIDER
INDICATED FOR HARD-TO-HEAL WOUNDS
* ENTERED A GLOBAL COLLABORATION TO COMMERCIALIZE CHLORASOLV
* RLS WILL RECEIVE MILESTONE PAYMENTS OF APPROXIMATELY SEK
40
MILLION ALLOCATED TO CLINICAL MILESTONES, OF WHICH APPROXIMATELY
SEK 15 MILLION UPON SIGNING
* CONVATEC PURCHASES CHLORASOLV AT A NEGOTIATED FIXED
TRANSFER
PRICE AND ALSO REMUNERATES RLS WITH A ROYALTY OF UP TO 15% OF
NET SALES
* AGREEMENT ALSO INCLUDES THAT CONVATEC HAS A RIGHT OF FIRST
REFUSAL FOR DISTRIBUTION OF CHLORASOLV IN OTHER MARKETS, AS WELL
AS NEW FUTURE INDICATIONS IN WOUND CARE AND OTHER TYPES OF
AGREEMENTS
Source text for Eikon: ID:nWkr1cJhCM
Further company coverage: RLSC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))